GNPX
GNPX
NASDAQ · Biotechnology

Genprex Inc

$4.32
-0.55 (-11.29%)
As of Aug 15, 2:38 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +540.3% upside
Low Target $20.34
Average Target $27.66
High Target $35.38
Current Price $4.32
Current
$4.32
Target
$27.66
$20.34 $27.66 avg $35.38
Scenario Analysis
Bear Case
$20.34
370.8%
Low target
Base Case
$27.66
+540.3%
Avg target
Bull Case
$35.38
+719.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
Target vs 52W High
$27.66
-97.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%